Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | — | IQVIA HLDGS INC | — | 26,500.0 | $6.0M | 0.56% | NEW | — | $225.41 | — |
| 62 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 153,278.0 | $5.3M | 0.50% | NEW | — | $34.71 | -0.1% |
| 63 | ELV | ELEVANCE HEALTH INC | Healthcare | 15,000.0 | $5.3M | 0.49% | NEW | — | $350.55 | +11.3% |
| 64 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 142,571.0 | $5.2M | 0.48% | NEW | — | $36.29 | -24.7% |
| 65 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 364,000.0 | $4.8M | 0.45% | NEW | — | $13.18 | +51.4% |
| 66 | CRL | CHARLES RIV LABS INTL INC | Healthcare | 22,000.0 | $4.4M | 0.41% | NEW | — | $199.48 | +14.4% |
| 67 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1,595,327.0 | $4.4M | 0.41% | NEW | — | $2.73 | +73.6% |
| 68 | VCEL | VERICEL CORP | Healthcare | 117,000.0 | $4.2M | 0.39% | NEW | — | $36.01 | +29.7% |
| 69 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 98,627.0 | $4.1M | 0.38% | NEW | — | $41.21 | +142.4% |
| 70 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 460,000.0 | $3.9M | 0.36% | NEW | — | $8.46 | +130.6% |
| 71 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 35,000.0 | $3.7M | 0.35% | NEW | — | $107.04 | +2.5% |
| 72 | OSCR | OSCAR HEALTH INC | Healthcare | 260,000.0 | $3.7M | 0.35% | NEW | — | $14.37 | +113.0% |
| 73 | ALKS | ALKERMES PLC | Healthcare | 133,250.0 | $3.7M | 0.35% | NEW | — | $27.98 | +85.8% |
| 74 | RDNT | RADNET INC | Healthcare | 47,000.0 | $3.4M | 0.31% | NEW | — | $71.35 | -13.9% |
| 75 | INSP | INSPIRE MED SYS INC | Healthcare | 35,800.0 | $3.3M | 0.31% | NEW | — | $92.23 | -45.2% |
| 76 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 265,000.0 | $3.2M | 0.30% | NEW | — | $12.14 | -18.0% |
| 77 | — | ASCENDIS PHARMA A/S | — | 15,000.0 | $3.2M | 0.30% | NEW | — | $213.24 | — |
| 78 | JANX | JANUX THERAPEUTICS INC | Healthcare | 225,377.0 | $3.1M | 0.29% | NEW | — | $13.80 | +16.2% |
| 79 | PRVA | PRIVIA HEALTH GROUP INC | Healthcare | 125,000.0 | $3.0M | 0.28% | NEW | — | $23.71 | +18.5% |
| 80 | STVN | STEVANATO GROUP S P A | Healthcare | 147,025.0 | $3.0M | 0.28% | NEW | — | $20.12 | -6.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%